Rosalind Advisors’s Verastem VSTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$15.2M Buy
3,986,509
+1,848,034
+86% +$8.94M 5.66% 5
2026
Q1
$11.3M Buy
2,138,475
+350,000
+20% +$2.16M 4.55% 10
2025
Q4
$13.8M Sell
1,788,475
-141,088
-7% -$1.26M 4.85% 7
2025
Q3
$17M Sell
1,929,563
-114,000
-6% -$848K 5.82% 4
2025
Q2
$8.48M Sell
2,043,563
-600,954
-23% -$3.76M 4.02% 9
2025
Q1
$15.9M Buy
2,644,517
+1,744,517
+194% +$10.7M 7.75% 2
2024
Q4
$4.65M Buy
+900,000
New +$3.54M 2.38% 16

Other funds holding VSTM

Rosalind Advisors's VSTM Position: Q2 2026 in Review

Rosalind Advisors increased its Verastem (VSTM) stake by 86% in Q2 2026, buying an estimated $8.94M and bringing the position to 3,986,509 shares worth $15.2M. The position accounts for 5.66% of the portfolio, ranked #5.

Rosalind Advisors first reported a position in VSTM in Q4 2024 and has held it in 7 quarters since. The position peaked at $17M in Q3 2025. 157 funds tracked by Wall St. Rank hold VSTM as of Q2 2026.

  • Rosalind Advisors held 3,986,509 shares of Verastem worth $15.2M as of Q2 2026.
  • Rosalind Advisors bought 1,848,034 Verastem shares in Q2 2026, an estimated $8.94M.
  • Verastem made up 5.66% of Rosalind Advisors's portfolio in Q2 2026, its #5 holding.
  • Rosalind Advisors first reported a position in Verastem in Q4 2024 and has held it in 7 quarters since.
  • Rosalind Advisors's Verastem position peaked at $17M in Q3 2025.
  • 157 funds tracked by Wall St. Rank held Verastem as of Q2 2026.

Based on Rosalind Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.